Disc Medicine (IRON) Cash & Equivalents Growth (1y) (2021 - 2026)
Disc Medicine (IRON) Cash & Equivalents Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash & Equiv. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
988.88% |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
-68.22% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
0.00% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
4.77% |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
3.35% |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
269.98% |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
17.50% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Disc Medicine |
2.62 Bn |
1.89 Bn |
- |
-27.52% |
| Date | Value |
|---|
| Mar 31, 2026 |
-27.52% |
| Dec 31, 2025 |
-52.64% |
| Sep 30, 2025 |
-26.98% |
| Jun 30, 2025 |
-54.63% |
| Mar 31, 2025 |
-64.19% |
| Dec 31, 2024 |
-46.60% |
| Sep 30, 2024 |
-48.01% |
| Jun 30, 2024 |
-25.67% |
| Mar 31, 2024 |
44.92% |
| Dec 31, 2023 |
85.18% |
| Sep 30, 2023 |
264.31% |
| Jun 30, 2023 |
247.51% |
| Mar 31, 2023 |
98.55% |
| Dec 31, 2022 |
121.06% |
| Sep 30, 2022 |
-32.23% |
| Jun 30, 2022 |
-34.78% |
| Mar 31, 2022 |
-35.31% |
| Dec 31, 2021 |
1,855.05% |
| Sep 30, 2021 |
10,336.48% |
